http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5668001-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75a4e06071f555a5c6ef8893d2aff09e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-88
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-60
filingDate 1994-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1997-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_538e7d349494fadb21ee9192dcc04a1a
publicationDate 1997-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5668001-A
titleOfInvention 3-hydroxy-3-methyl-glutaryl-coa synthase preparation with improved stability
abstract A preparation of recombinant 3-hydroxy-3-methylglutaryl-CoA synthase is disclosed, wherein the preparation has at least 0.024 units/mg specific activity. Preferably, the preparation has at least 0.24 units/mg specific activity and is a crude cell extract. Preferably, at least 90% of the synthase molecules have not been substantially proteolytically cleaved. A preparation of recombinant HMG-CoA synthase wherein the preparation retains 50% activity after storage at 4 DEG C. for six months is also disclosed. A method of evaluating the efficacy of candidate anti-isoprene and anti-cholesterol drugs is also disclosed which comprises exposing the candidate drug to a recombinant 3-hydroxy-3-methylglutaryl CoA synthase preparation.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005164245-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006292563-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03103597-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03103597-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004058338-A1
priorityDate 1993-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136119332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226442342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394009
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4032669
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128383593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444493
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17796899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128148610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128121089
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11025495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129608836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135902157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226438035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226444371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226572792
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226444372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127351521
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5090721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226444373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22876880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18461970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22819629
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15575779

Total number of triples: 51.